Joseph A Ippolito

This inventor holds 16 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Bioversys Ag, Rib-X Pharmaceuticals, Inc., Yale University. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A Ippolito. Retrieved from https://idiyas.com/inventor/joseph-a-ippolito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 9)

% Patents Active = 68.8

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 62(Granted Patents)

Company Filing History:

Rib-X Pharmaceuticals, Inc.

Melinta Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297201 - Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials (2025-05-13),

2. 12234238 - Antimicrobial compounds and methods of making and using the same (2025-02-25),

3. 12152031 - Biodefense agents (2024-11-26),

4. 11999739 - Antimicrobials methods of making and using the same (2024-06-04),

5. 11098047 - Antimicrobials and methods of making and using same (2021-08-24),

6. 10934295 - Antimicrobials and methods of making and using same (2021-03-02),

7. 10815237 - Antimicrobials and methods of making and using same (2020-10-27),

8. 8912150 - Ribosome structure and protein synthesis inhibitors (2014-12-16),

9. 8841263 - Macrocyclic compounds and methods of making and using the same (2014-09-23),

10. 8470990 - Ribosome structure and protein synthesis inhibitors (2013-06-25),

11. 8202843 - Macrocyclic compounds and methods of making and using the same (2012-06-19),

12. 7666849 - Ribosome structure and protein synthesis inhibitors (2010-02-23),

13. 7335753 - Bifunctional heterocyclic compounds and methods of making and using same (2008-02-26),

14. 7091196 - Bifunctional heterocyclic compounds and methods of making and using same (2006-08-15),

15. 6952650 - Modulators of ribosomal function and identification thereof (2005-10-04),

Title: Joseph A Ippolito: Innovator in Antimicrobial Compounds

Introduction

Joseph A Ippolito is a notable inventor based in Guilford, CT (US), recognized for his significant contributions to the field of antimicrobial compounds. With a total of 16 patents to his name, Ippolito has made strides in developing innovative solutions for treating microbial infections in both humans and animals.

Latest Patents

Ippolito's latest patents include "Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials." This patent relates to the field of antimicrobial compounds and outlines methods for making and using these compounds. The compounds are designed to treat, prevent, reduce the risk of, and delay the onset of microbial infections. Another significant patent is "Antimicrobial compounds and methods of making and using the same," which also focuses on similar applications in combating microbial infections.

Career Highlights

Throughout his career, Joseph A Ippolito has worked with several prominent companies, including Bioversys AG and Rib-X Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in antimicrobial research and development.

Collaborations

Ippolito has collaborated with notable professionals in his field, including Ashoke Bhattacharjee and Erin M Duffy. These collaborations have further enhanced his research and innovation in antimicrobial compounds.

Conclusion

Joseph A Ippolito stands out as a significant figure in the development of antimicrobial solutions, with a robust portfolio of patents and collaborations that underscore his impact in the field. His work continues to influence the fight against microbial infections, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.